Back to search

Peptide record

TPDB43079

HTLV-II-Rex-2D5 Anticancer standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43079
HTLV-II-Rex-2D5
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 21-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
TRRQRTRRARRNRGGLTIYFY
Physicochemical Analysis
C115H193N47O29
DCEHKMPSWV
R
2698.10
12.62
8
0
6
+8
3.87
-1.695
41.90
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
2980
110.45
7
Residue Composition
number
1
A
8
R
1
N
0
D
0
C
0
E
1
Q
2
G
0
H
1
I
1
L
0
K
0
M
1
F
0
P
0
S
3
T
0
W
2
Y
0
V
Amino Acid Distribution
A: 1 R: 8 N: 1 D: 0 C: 0 E: 0 Q: 1 G: 2 H: 0 I: 1 L: 1 K: 0 M: 0 F: 1 P: 0 S: 0 T: 3 W: 0 Y: 2 V: 0
Chemical Descriptors
21
C115H193N47O29
2698.10
12.62
+8
3.87
-1.695
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph figure 1-G
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.